Development and Biopharmaceutical Evaluation of Tablets Based on the Poorly Water-soluble Substance 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil
Introduction. 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil is a substance of scientific interest intended for the treatment of HIV-infection. However, its low bioavailability is a major limitation in successful drug delivery by oral route. Therefore, the objective of the present work was to enhance...
Saved in:
Main Authors: | D. V. Demchenko, E. A. Jain (Korsakova), V. Yu. Balabanyan, M. N. Makarova, V. G. Makarov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-11-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/835 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT AND VALIDATION OF THE PROCEDURE FOR QUANTIFICATION OF COMPOUND VMU-2012-05 (1-[2-(2-BENZOYLPHENOXY)ETHYL]-6-METHYLURACIL) IN TABLETS
by: T. M. TISHKOV, et al.
Published: (2018-02-01) -
Comparative Pharmacokinetics Study of 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil Substance and its Solid Dispersion Systems on Rabbits
by: V. M. Kosman, et al.
Published: (2021-05-01) -
CHARACTERISATION AND STUDY OF 1- [2- (2-BENZOYLPHENOXY) ETHYL] -6-METHYLURACIL MECHANISM OF ACTION
by: E. A. Jain (Korsakova), et al.
Published: (2021-07-01) -
EXPERIMENTAL STUDY OF TOXIC PROPERTIES OF VMU-2012-05 DRUG – ORIGINAL NON-NUCLEESIDE INHIBITOR OF HIV-1 REVERSE TRANSCRIPTASE
by: V. A. Vavilova, et al.
Published: (2021-08-01) -
EVALUATION OF THE AUTOMATION INFLUENCE ON THE DISSOLUTION VARIABILITY RESULTS FOR BETASERC TABLETS
by: N. S. Dubovik, et al.
Published: (2019-01-01)